| Comprehensive molecular portraits of human breast tumours Brigham & Women’s Hospital & Harvard Medical School Chin Lynda 9 11 Park ... Nature 490 (7418), 61-70, 2012 | 11018 | 2012 |
| Comprehensive molecular characterization of human colon and rectal cancer Cancer Genome Atlas Network Nature 487 (7407), 330, 2012 | 7373 | 2012 |
| Integrated genomic analyses of ovarian carcinoma D Bell, A Berchuck, M Birrer, J Chien, DW Cramer, F Dao, R Dhir, P Disaia, ... Nature Publishing Group 474 (7353), 609-615, 2011 | 6800 | 2011 |
| Integrated genomic characterization of endometrial carcinoma DA Levine, ... Nature 497 (7447), 67-73, 2013 | 4781 | 2013 |
| Comprehensive genomic characterization of squamous cell lung cancers Cancer Genome Atlas Research Network Nature 489 (7417), 519, 2012 | 3641 | 2012 |
| Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM CJ Vaske, SC Benz, JZ Sanborn, D Earl, C Szeto, J Zhu, D Haussler, ... Bioinformatics 26 (12), i237-i245, 2010 | 864 | 2010 |
| Distributed machine learning systems, apparatus, and methods C Szeto, SC Benz, NJ Witchey US Patent 11,461,690, 2022 | 267 | 2022 |
| Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition GS Wong, J Zhou, JB Liu, Z Wu, X Xu, T Li, D Xu, SE Schumacher, ... Nature medicine 24 (7), 968-977, 2018 | 232 | 2018 |
| The UCSC cancer genomics browser J Zhu, JZ Sanborn, S Benz, C Szeto, F Hsu, RM Kuhn, D Karolchik, ... Nature methods 6 (4), 239-240, 2009 | 201 | 2009 |
| A deep learning image-based intrinsic molecular subtype classifier of breast tumors reveals tumor heterogeneity that may affect survival MI Jaber, B Song, C Taylor, CJ Vaske, SC Benz, S Rabizadeh, ... Breast Cancer Research 22, 1-10, 2020 | 83 | 2020 |
| The UCSC cancer genomics browser: update 2011 JZ Sanborn, SC Benz, B Craft, C Szeto, KM Kober, L Meyer, CJ Vaske, ... Nucleic acids research 39 (suppl_1), D951-D959, 2011 | 73 | 2011 |
| The multi-functionality of N-809, a novel fusion protein encompassing anti-PD-L1 and the IL-15 superagonist fusion complex C Jochems, SR Tritsch, KM Knudson, SR Gameiro, CS Rumfield, ... Oncoimmunology 8 (2), e1532764, 2019 | 36 | 2019 |
| Treatment with checkpoint inhibitors in a metastatic colorectal cancer patient with molecular and immunohistochemical heterogeneity in MSI/dMMR status F Loupakis, G Maddalena, I Depetris, S Murgioni, F Bergamo, AP Dei Tos, ... Journal for ImmunoTherapy of Cancer 7, 1-7, 2019 | 29 | 2019 |
| Transcriptomic silencing as a potential mechanism of treatment resistance JJ Adashek, S Kato, R Parulkar, CW Szeto, JZ Sanborn, CJ Vaske, ... JCI insight 5 (11), 2020 | 26 | 2020 |
| Large scale, robust, and accurate whole transcriptome profiling from clinical formalin-fixed paraffin-embedded samples Y Newton, AJ Sedgewick, L Cisneros, J Golovato, M Johnson, CW Szeto, ... Scientific reports 10 (1), 17597, 2020 | 25 | 2020 |
| Ensemble-Based Research Recommendation Systems And Methods C Szeto US Patent App. 15/555,290, 2018 | 16 | 2018 |
| Complete response to avelumab and IL-15 superagonist N-803 with Abraxane in Merkel cell carcinoma: a case study L Drusbosky, C Nangia, A Nguyen, C Szeto, Y Newton, P Spilman, ... Journal for immunotherapy of cancer 8 (2), 2020 | 11 | 2020 |
| Refining the selection of patients with metastatic colorectal cancer for treatment with temozolomide using proteomic analysis of O6-methylguanine-DNA-methyltransferase S Schwartz, C Szeto, Y Tian, F Cecchi, S Corallo, MA Calegari, ... European Journal of Cancer 107, 164-174, 2019 | 11 | 2019 |
| Association of differential expression of immunoregulatory molecules and presence of targetable mutations may inform rational design of clinical trials CW Szeto, R Kurzrock, S Kato, A Goloubev, S Veerapaneni, A Preble, ... ESMO open 7 (1), 100396, 2022 | 10 | 2022 |
| Impact of HLA-DR antigen binding cleft rigidity on T cell recognition C Szeto, JI Bloom, H Sloane, CA Lobos, J Fodor, D Jayasinghe, ... International journal of molecular sciences 21 (19), 7081, 2020 | 10 | 2020 |
David HausslerScientific Director, UC Santa Cruz Genomics Institute, University of California, Santa CruzDirección de correo verificada de soe.ucsc.edu
